Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Whirlin is a large multidomain scaffolding protein essential for sensory neuron function, notably in the auditory and visual systems. It localizes to structures critical for hearing (stereocilia of hair cells in the inner ear) and vision (periciliary membrane complex in retina photoreceptors). The protein is necessary for the proper elongation and maintenance of hair cell stereocilia, as well as for the organization of protein complexes important for mechanotransduction and phototransduction. Mutations in WHRN lead to varying forms of sensorineural deafness and are a principal genetic cause of Usher syndrome type 2D, which combines congenital hearing loss with progressive retinal degeneration. Whirlin interacts with several other Usher syndrome proteins, forming a complex that is fundamental to the development and stability of sensory cellular architectures. No drugs currently target whirlin directly, and its primary clinical significance lies in genetic diagnosis and potential research into gene therapies for Usher syndrome. Whirlin/WHRN is not a receptor, enzyme, transporter, or canonical drug target but is a critical scaffolding/signaling protein in sensory cells. The principal involvement is as a disease gene rather than a pharmacological target; mutations cause hereditary deafness and Usher syndrome. While not presently a therapeutic target, it is a vital biomarker for genetic forms of deafness and syndromic vision loss.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Whirlin (WHRN).